Iterum Therapeutics plc (ITRM) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Dublin, 爱尔兰. 现任CEO为 Corey N. Fishman.
ITRM 拥有 IPO日期为 2018-05-25, 9 名全职员工, 在 NASDAQ Capital Marke, 市值为 $1.6M.
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
